Poland
# |
Name |
Share Price |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 12.20 |
Feb. 3, 2025 | USD 12.20 | -4.46% |
|
Poland |
|
2 |
USD 10.51 |
Feb. 3, 2025 | USD 10.51 | -3.97% |
|
Poland |
|
3 |
USD 9.53 |
Feb. 3, 2025 | USD 9.53 | 2.20% |
|
Poland |
|
4 |
USD 6.53 |
Feb. 3, 2025 | USD 6.53 | 2.36% |
|
Poland |
|
5 |
USD 2.23 |
Feb. 3, 2025 | USD 2.23 | -2.90% |
|
Poland |
|
6 |
USD 1.79 |
Feb. 3, 2025 | USD 1.79 | -1.96% |
|
Poland |
The Clinical Trials company in Poland with the highest Share Price is Captor Therapeutics Spolka Akcyjna (Warsaw Stock Exchange: CTX.WA) at USD 12.20.
The Clinical Trials company in Poland with the lowest Share Price is Medinice S.A. (Warsaw Stock Exchange: ICE.WA) at USD 1.79.
The top 10 Clinical Trials companies in Poland by Share Price are Captor Therapeutics Spolka Akcyjna, Selvita S.A., Poltreg S.A., Ryvu Therapeutics S.A., Molecure S.A. and Medinice S.A..
The bottom 10 Clinical Trials companies in Poland by Share Price are Medinice S.A., Molecure S.A., Ryvu Therapeutics S.A., Poltreg S.A., Selvita S.A. and Captor Therapeutics Spolka Akcyjna.